Identification of circulating protein biomarkers in patients with hepatocellular carcinoma concomitantly infected with chronic hepatitis C virus

References

• Anderson, N.L. and Anderson, N.G. 2002. The human plasma proteome: history, character, and diagnostic prospects. Molecular and cellular proteomics, 1, 845–867.
   PubMed Web of Science ®Google Scholar
• Banerjee, A., Ray, R.B., and Ray, R. 2010. Oncogenic potential of hepatitis C virus proteins. Viruses, 2, 2108–2133.
   PubMed Web of Science ®Google Scholar
• Bioulac-Sage, P., et al., 2007. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology, 46, 740–748.
   PubMed Web of Science ®Google Scholar
• Correale, M., et al., 1999. Serum 90K/MAC-2BP glycoprotein levels in hepatocellular carcinoma and cirrhosis. Anticancer research, 19, 3469–3472.
   PubMed Web of Science ®Google Scholar
• Davis, G.L., et al., 2008. Hepatocellular carcinoma: management of an increasingly common problem. Proceedings (Baylor University Medical Center), 21, 266–280.
   PubMedGoogle Scholar
• De Oliveria Andrade, L.J., et al., 2009. Association between hepatitis C and hepatocellular carcinoma. Journal of Global Infectious Disease, 1, 33–37.
   PubMedGoogle Scholar
• Dennis, G. Jr., et al., 2003. DAVID: database for annotation, visualization, and integrated discovery. Genome biology, 4, P3.
   PubMed Web of Science ®Google Scholar
• Diamandis, E.P. 2004. Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Molecular and cellular proteomics, 3:367–378.
   PubMed Web of Science ®Google Scholar
• Douglas, D.N., et al., 2016. Oxidative stress attenuates lipid synthesis and increases mitochondrial fatty acid oxidation in hepatoma cells infected with hepatitis C virus. Journal of biological chemistry, 291:1974–1990.
   PubMed Web of Science ®Google Scholar
• EL-Serag, H.B., 2012. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142:1264–1273 e1.
   PubMed Web of Science ®Google Scholar
• Fang, T., et al., 2015. Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein beta in hepatocellular carcinomas. Oncotarget, 6, 16106–16119.
   PubMed Web of Science ®Google Scholar
• Farinati, F., et al., 2007. Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma. Journal of viral hepatalogy, 14, 821–829.
   PubMed Web of Science ®Google Scholar
• Farkas, I.J., Szanto-Varnagy, A., and Korcsmaros, T. 2012. Linking proteins to signaling pathways for experiment design and evaluation. PLoS One, 7, e36202.
   PubMed Web of Science ®Google Scholar
• Forner, A. and Bruix, J. 2012. Biomarkers for early diagnosis of hepatocellular carcinoma. Lancet oncology, 13, 750–1.
   PubMed Web of Science ®Google Scholar
• Gao, H.J., et al., 2015. Quantitative proteomic analysis for high-throughput screening of differential glycoproteins in hepatocellular carcinoma serum. Cancer biology and medicine, 12, 246–254.
   PubMedGoogle Scholar
• Germano, D. and Daniele, B. 2014. Systemic therapy of hepatocellular carcinoma: current status and future perspectives. World journal of gastroenterology, 20, 3087–3099.
   PubMed Web of Science ®Google Scholar
• Gursoy, S., et al., 2005. Importance of anticoagulant proteins in chronic liver diseases. Turkish journal of gastroenterology, 16, 129–133.
   PubMedGoogle Scholar
• Hamm, A., et al., 2008. Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis. BMC Cancer, 8, 25.
   PubMed Web of Science ®Google Scholar
• He, X., et al., 2014. Screening differential expression of serum proteins in AFP-negative HBV-related hepatocellular carcinoma using iTRAQ -MALDI-MS/MS. Neoplasma, 61, 17–26.
   PubMed Web of Science ®Google Scholar
• Ho, A.S., et al., 2010. Novel biomarkers predict liver fibrosis in hepatitis C patients: alpha 2 macroglobulin, vitamin D binding protein and apolipoprotein AI. Journal of biomedical science, 17, 58.
   PubMed Web of Science ®Google Scholar
• Huang, C., et al., 2013. Quantitative proteomic analysis identified paraoxonase 1 as a novel serum biomarker for microvascular invasion in hepatocellular carcinoma. Journal of proteome research, 12, 1838–1846.
   PubMed Web of Science ®Google Scholar
• Iacovazzi, P.A., et al., 2001. Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein. Clinical chemistry and laboratory medicine, 39, 961–965.
   PubMed Web of Science ®Google Scholar
• Ivanov, A.V., et al., 2013. HCV and oxidative stress in the liver. Viruses, 5, 439–469.
   PubMed Web of Science ®Google Scholar
• Kamada, Y., et al., 2013. Serum Mac-2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitis. Proteomics clinical applications, 7, 648–56.
   PubMed Web of Science ®Google Scholar
• Khadem Ansari, M.H., Omrani, M.D., and Kheradmand, F. 2015. Oxidative stress response in patients infected by diverse hepatitis C virus genotypes. Hepatitis monthly, 15, e22069.
   PubMed Web of Science ®Google Scholar
• Kittl, E.M., et al., 2000. Serum protein 90K/Mac-2BP is an independent predictor of disease severity during hepatitis C virus infection. Clinical chemistry and laboratory medicine, 38, 205–208.
   PubMed Web of Science ®Google Scholar
• Lange, C.M., et al., 2013. Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development. PLoS One, 8, e64053.
   PubMed Web of Science ®Google Scholar
• Lozano-Sepulveda, S.A., et al., 2015. Oxidative stress modulation in hepatitis C virus infected cells. World journal of hepatology, 7, 2880–2889.
   PubMedGoogle Scholar
• Megger, D.A., et al., 2014. Proteome analyses of hepatocellular carcinoma. Journal of clinical and translational hepatology, 2:23–30.
   PubMedGoogle Scholar
• Montalto, G., et al., 2002. Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Annals of New York Academy of Sciences, 963, 13–20.
   PubMed Web of Science ®Google Scholar
• Motawi, T.K., et al., 2015. Serum microRNAs as potential biomarkers for early diagnosis of hepatitis C virus-related hepatocellular carcinoma in Egyptian patients. PLoS One, 10:e0137706.
   PubMed Web of Science ®Google Scholar
• Ni, X.C., et al., 2014. Serum amyloid A is a novel prognostic biomarker in hepatocellular carcinoma. Asian Pacific Journal of Cancer Prevention, 15, 10713.
   PubMedGoogle Scholar
• Noh, C.K., et al., 2014. Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma. Clinical biochemistry, 47, 1257–1261.
   PubMed Web of Science ®Google Scholar
• Otegbayo, J.A., et al., 2005. Usefulness of acute phase proteins for monitoring development of hepatocellular carcinoma in hepatitis B virus carriers. West African Journal of medicine, 24, 124–127.
   PubMedGoogle Scholar
• Shaker, M.K., et al., 2013. Epidemiological characteristics of hepatocellular carcinoma in Egypt: a retrospective analysis of 1313 cases. Liver international, 33:1601–1606.
   PubMed Web of Science ®Google Scholar
• Shu, H., et al., 2010. Diagnostic value of serum haptoglobin protein as hepatocellular carcinoma candidate marker complementary to alpha fetoprotein. Oncology reports, 24, 1271–1276.
   PubMed Web of Science ®Google Scholar
• Sox, H.C., et al., 1989. Medical decision making, London, UK: Butterworth.
   Google Scholar
• Szklarczyk, D., et al., 2015. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic acids research, 43, D447–D452.
   PubMed Web of Science ®Google Scholar
• Tang, Y., et al., 2008. Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling. Proceedings of the National Academy of Sciences USA, 105, 2445–2450.
   PubMed Web of Science ®Google Scholar
• Tinkle, C.L. and Haas-Kogan, D. 2012. Hepatocellular carcinoma: natural history, current management, and emerging tools. Biologics, 6, 207–219.
   PubMedGoogle Scholar
• Tsai, T.H., et al., 2015. LC-MS/MS-based serum proteomics for identification of candidate biomarkers for hepatocellular carcinoma. Proteomics, 15, 2369–2381.
   PubMed Web of Science ®Google Scholar
• Tsuchiya, N., et al., 2015. Biomarkers for the early diagnosis of hepatocellular carcinoma. World journal of gastroenterology, 21, 10573–83.
   PubMed Web of Science ®Google Scholar
• Vaisar, T., et al., 2007. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. Journal of clinical investigation, 117, 746–756.
   PubMed Web of Science ®Google Scholar
• Vespasiani-Gentilucci, U., et al., 2014. Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis. World journal of gastroenterology, 20, 2825–2838.
   PubMed Web of Science ®Google Scholar
• Wang, F., et al., 2012. Identification of ZAG protein as a novel serologic biomarker candidate for liver cancer. Advanced materials research, 340, 383–389.
   Google Scholar
• Wu, F.X., et al., 2009. Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy. Cancer letters, 279, 163–170.
   PubMed Web of Science ®Google Scholar
• Wu, J.M., Skill, N.J., and Maluccio, M.A. 2010. Evidence of aberrant lipid metabolism in hepatitis C and hepatocellular carcinoma. HPB (Oxford), 12, 625–636.
   PubMed Web of Science ®Google Scholar
• Yang, L., et al., 2011. Novel biomarker candidates to predict hepatic fibrosis in hepatitis C identified by serum proteomics. Digestive diseases and sciences, 56, 3305–3315.
   PubMed Web of Science ®Google Scholar
• Zhang, H., et al., 2015a. KRT6B, a key mediator of notch signaling in honokiol-induced human hepatoma cell apoptosis. International journal of clinical and experimental medicine, 8, 16880–16889.
   PubMed Web of Science ®Google Scholar
• Zhang, S., et al., 2015b. Serum fucosylated paraoxonase 1 as a potential glycobiomarker for clinical diagnosis of early hepatocellular carcinoma using ELISA Index. Glycoconjugate journal, 32, 119–125.
   PubMed Web of Science ®Google Scholar